APA

Bassand J. P., Toubin G., Magnin A., Molnar A., Schmidt P. M., Maurat J. P., Bechtel P. & Perret C. (19760430). [Proceedings: Erythrocyte 2,3-diphosphoglycerate during the development of myocardial infarct. Concerning 118 cases]. : Schweizerische medizinische Wochenschrift.

Chicago

Bassand J P, Toubin G, Magnin A, Molnar A, Schmidt P M, Maurat J P, Bechtel P and Perret C. 19760430. [Proceedings: Erythrocyte 2,3-diphosphoglycerate during the development of myocardial infarct. Concerning 118 cases]. : Schweizerische medizinische Wochenschrift.

Harvard

Bassand J. P., Toubin G., Magnin A., Molnar A., Schmidt P. M., Maurat J. P., Bechtel P. and Perret C. (19760430). [Proceedings: Erythrocyte 2,3-diphosphoglycerate during the development of myocardial infarct. Concerning 118 cases]. : Schweizerische medizinische Wochenschrift.

MLA

Bassand J P, Toubin G, Magnin A, Molnar A, Schmidt P M, Maurat J P, Bechtel P and Perret C. [Proceedings: Erythrocyte 2,3-diphosphoglycerate during the development of myocardial infarct. Concerning 118 cases]. : Schweizerische medizinische Wochenschrift. 19760430.